12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Cellectis, Iowa State University deal

Cellectis received two exclusive licenses from the university covering technologies related to transcription activator-like effector nucleases (TALENs) and monomeric...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >